Zhang Financial LLC lifted its position in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 2.4% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 24,126 shares of the company’s stock after buying an additional 563 shares during the quarter. Zhang Financial LLC’s holdings in Procter & Gamble were worth $3,535,000 at the end of the most recent quarter.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Wyrmwood Management LLC purchased a new stake in Procter & Gamble during the fourth quarter valued at about $29,000. Mendota Financial Group LLC lifted its stake in Procter & Gamble by 636.6% during the fourth quarter. Mendota Financial Group LLC now owns 302 shares of the company’s stock valued at $44,000 after buying an additional 261 shares in the last quarter. Itau Unibanco Holding S.A. purchased a new stake in Procter & Gamble during the second quarter valued at about $50,000. Morton Brown Family Wealth LLC lifted its stake in Procter & Gamble by 206.6% during the fourth quarter. Morton Brown Family Wealth LLC now owns 417 shares of the company’s stock valued at $61,000 after buying an additional 281 shares in the last quarter. Finally, Activest Wealth Management lifted its stake in Procter & Gamble by 49.7% during the fourth quarter. Activest Wealth Management now owns 455 shares of the company’s stock valued at $67,000 after buying an additional 151 shares in the last quarter. Institutional investors own 65.77% of the company’s stock.
Procter & Gamble Stock Performance
PG stock traded up $0.17 during midday trading on Friday, hitting $157.46. 6,684,953 shares of the company traded hands, compared to its average volume of 6,859,360. The business has a 50 day simple moving average of $159.13 and a 200-day simple moving average of $152.83. The stock has a market capitalization of $370.51 billion, a price-to-earnings ratio of 26.31, a price-to-earnings-growth ratio of 3.21 and a beta of 0.44. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48. The Procter & Gamble Company has a twelve month low of $141.45 and a twelve month high of $163.14.
Procter & Gamble Increases Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be paid a $1.0065 dividend. This is an increase from Procter & Gamble’s previous quarterly dividend of $0.94. The ex-dividend date is Thursday, April 18th. This represents a $4.03 annualized dividend and a dividend yield of 2.56%. Procter & Gamble’s dividend payout ratio (DPR) is presently 67.34%.
Analysts Set New Price Targets
PG has been the subject of a number of analyst reports. UBS Group upped their price objective on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft increased their price target on shares of Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Barclays increased their price target on shares of Procter & Gamble from $165.00 to $168.00 and gave the stock an “overweight” rating in a research report on Friday, April 12th. Finally, The Goldman Sachs Group began coverage on Procter & Gamble in a report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price objective on the stock. Seven analysts have rated the stock with a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $168.53.
Check Out Our Latest Research Report on Procter & Gamble
Insider Transactions at Procter & Gamble
In related news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction on Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO Gary A. Coombe sold 22,000 shares of the firm’s stock in a transaction on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total value of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at $5,943,835.40. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 279,063 shares of company stock worth $43,187,745. Insiders own 0.17% of the company’s stock.
Procter & Gamble Profile
The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.
Further Reading
- Five stocks we like better than Procter & Gamble
- Dividend Capture Strategy: What You Need to Know
- Comprehensive Analysis of PayPal Stock
- How to Invest in Biotech Stocks
- Intuitive Surgical Stock Can Trend Much Higher This Year
- What Does a Stock Split Mean?
- Alibaba Stock Analysis: Insights, Trends, and Future Predictions
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.